Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$207,707,380
-$165,756,275 QoQ
Shares Held
1,644,035
-38.6% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#88
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KBC Group NV holds $2,157,048,254 across 10 Drug Manufacturers - General names. GILD ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
544,998 | $653,687,004 | |
| 2 | JNJ |
Johnson & Johnson
|
1,322,168 | $335,791,005 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,264,357 | $245,712,249 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
1,644,035 | $207,707,380 | |
| 5 | PFE |
Pfizer Inc
|
8,327,265 | $200,520,541 | |
| 6 | ABBV |
AbbVie Inc.
|
672,932 | $169,336,607 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,131,286 | $145,370,250 | |
| 8 | AMGN |
Amgen Inc
|
382,676 | $138,574,632 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $207,707,380 | 1,644,035 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $373,463,655 | 2,679,656 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $398,245,394 | 3,244,626 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $328,667,337 | 2,960,967 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $259,634,589 | 2,341,793 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $206,741,774 | 1,845,085 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $190,427,035 | 2,061,568 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $191,366,392 | 2,282,519 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $248,863,289 | 3,627,216 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $231,409,715 | 3,159,177 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $115,160,574 | 1,421,560 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $92,682,419 | 1,236,755 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $111,555,355 | 1,447,455 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $77,329,699 | 932,020 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $73,207,728 | 852,740 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $49,093,950 | 795,817 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $47,463,774 | 767,898 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $41,042,198 | 690,365 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $65,735,575 | 905,324 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $57,897,197 | 828,879 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $43,236,574 | 627,891 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $33,187,504 | 513,500 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $27,638,951 | 474,407 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $35,287,191 | 558,430 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $40,796,742 | 530,241 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $45,447,051 | 607,906 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||